Literature DB >> 9284890

Diabetes mellitus associated with the 3243 mitochondrial tRNA(Leu)(UUR) mutation: insulin secretion and sensitivity.

Y Suzuki1, T Iizuka, T Kobayashi, T Nishikawa, Y Atsumi, T Kadowaki, Y Oka, H Kadowaki, M Taniyama, K Hosokawa, T Asahina, K Matsuoka.   

Abstract

To investigate the pathophysiology of diabetes mellitus associated with the 3243 mitochondrial tRNA(Leu)(UUR) mutation (DM-Mt3243), insulin secretion and sensitivity were studied using the 75-g oral glucose tolerance test (oGTT), 1-mg intravenous glucagon test, and euglycemic glucose clamp test. Twelve DM-Mt3243 patients were investigated (seven men and five women). Their ages ranged from 36 to 74 years, and the onset of diabetes occurred at 44.5 +/- 9.5 years (mean +/- SD). In the glucose tolerance test, nine patients (75.0%) showed lower C-peptide reactivity (CPR) than normal at 30 minutes, suggesting blunted insulin secretion. Three patients showed an impaired glucose tolerance (IGT) pattern, although they had absolute hyperglycemia at the onset of diabetes. In the glucagon test, 10 patients (76.3%) had CPR within the normal range at 6 minutes, indicating an adequate response. In the glucose clamp test, the M value was 8.70 +/- 2.35 mg/kg/min and was within normal limits in all patients. The glucose metabolized (M value) was negatively correlated with 24-hour urinary C-peptide excretion (r = .696, P < .05). Thus, plasma CPR to glucose loading was blunted in many DM-Mt3243 patients, but CPR to glucagon was relatively well preserved. This difference in the intrinsic insulin response to the two stimuli may be characteristic of DM-Mt3243. Although M values were normal in all subjects, the correlation with 24-hour urinary C-peptide excretion suggests a relationship between insulin sensitivity and insulin secretion. These two mechanisms may cooperate to maintain homeostasis in this disease. Since three patients did not progress with aging, this mutation may not always cause gradual beta-cell destruction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9284890     DOI: 10.1016/s0026-0495(97)90272-9

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  6 in total

Review 1.  Mitochondrially derived peptides as novel regulators of metabolism.

Authors:  Su-Jeong Kim; Jialin Xiao; Junxiang Wan; Pinchas Cohen; Kelvin Yen
Journal:  J Physiol       Date:  2017-07-18       Impact factor: 5.182

Review 2.  Mitochondrial diabetes mellitus.

Authors:  J A Maassen; G M C Janssen; H H J P Lemkes
Journal:  J Endocrinol Invest       Date:  2002-05       Impact factor: 4.256

3.  Mitochondrial polymorphisms and susceptibility to type 2 diabetes-related traits in Finns.

Authors:  Karen L Mohlke; Anne U Jackson; Laura J Scott; Erin C Peck; Yong D Suh; Peter S Chines; Richard M Watanabe; Thomas A Buchanan; Karen N Conneely; Michael R Erdos; Narisu Narisu; Sareena Enloe; Timo T Valle; Jaakko Tuomilehto; Richard N Bergman; Michael Boehnke; Francis S Collins
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

Review 4.  Mitochondrial Bioenergetics and Dynamics in Secretion Processes.

Authors:  Jennyfer Martínez; Inés Marmisolle; Doménica Tarallo; Celia Quijano
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-22       Impact factor: 5.555

5.  Mitochondrial mutation m.3243A>G associates with insulin resistance in non-diabetic carriers.

Authors:  Jakob Høgild Langdahl; Anja Lisbeth Frederiksen; John Vissing; Morten Frost; Knud Bonnet Yderstræde; Per Heden Andersen
Journal:  Endocr Connect       Date:  2019-07       Impact factor: 3.335

6.  m.3243A>G mutation in mitochondrial DNA leads to decreased insulin sensitivity in skeletal muscle and to progressive beta-cell dysfunction.

Authors:  Markus M Lindroos; Kari Majamaa; Andrea Tura; Andrea Mari; Kari K Kalliokoski; Markku T Taittonen; Patricia Iozzo; Pirjo Nuutila
Journal:  Diabetes       Date:  2008-12-10       Impact factor: 9.461

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.